Live
- ED attaches properties valued over Rs 55 cr in VMC Systems bank fraud case
- India carries out successful launch of medium-range ballistic missile's new version
- K'taka BJP files complaint with EC over Congress' protest on Vidhana Soudha premises
- Time for Global South to assume greater role: EAM Jaishankar at ASEAN meet
- Rajender Rao is Congress candidate for Karimnagar Lok Sabha : Ponnam
- Part-2 sequel of fraud of Congress is being witnessed by people: KTR
- DK Aruna obstructed construction of Narayanapet irrigation project: Revanth
- National Panchayati Raj Day 2024: Date, History, Significance, and Observance
- Unlock Radiant Skin: 10 Essential Foods for a Glowing Complexion
- Mamata Banerjee slams judiciary over court ruling in school jobs case
KTR extends wishes to Hyderabad biotech firm to develop vaccine for coronavirus
Telangana minister KT Rama Rao extended best wishes to Hyderabad biotech company Bharat Biotech which is striving to develop the 'CoroFlu' vaccine for the prevention of coronavirus.
Telangana minister KT Rama Rao extended best wishes to Hyderabad biotech company Bharat Biotech which is striving to develop the 'CoroFlu' vaccine for the prevention of coronavirus. The minister greeted the company managing director Dr. Krishna Ella and the team in the development of the vaccine.
My best wishes to our own Hyderabad Biotech company @BharatBiotech as they strive to develop a vaccine #CoroFlu for #CoronaVirus prevention
— KTR (@KTRTRS) April 4, 2020
Good luck in your endeavour CMD Dr. Krishna Ella and team. Wish you all success 👍 pic.twitter.com/Ivd1t3KePf
Bharat Biotech Ltd, a Hyderabad-based firm has joined hands with the University of Wisconsin-Madison and US-based company FluGen to develop 'CoroFlu'. The company said that the vaccine will be based on FluGen's flu vaccine candidate M2SR. "The gene sequences from coronavirus SARS-CoV2 will be placed into the vaccine candidate for additional immunity to fight against coronavirus," Bharat Biotech said.
Raches Ella, managing director of Bharat Biotech in a statement said that the company would produce 300 million doses of vaccine for global distribution.
